Anzeige
Mehr »
Dienstag, 18.11.2025 - Börsentäglich über 12.000 News
Die KI-Comeback-Story des Jahres 2025
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 913004 | ISIN: US7599101026 | Ticker-Symbol:
NASDAQ
17.11.25 | 21:51
4,500 US-Dollar
+3,93 % +0,170
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
KORU MEDICAL SYSTEMS INC Chart 1 Jahr
5-Tage-Chart
KORU MEDICAL SYSTEMS INC 5-Tage-Chart

Aktuelle News zur KORU MEDICAL SYSTEMS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoKORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025192KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions...
► Artikel lesen
DoKoru Medical Systems stock maintains Buy rating at Canaccord on strong growth1
DoKORU Medical Systems projects 20%-22% revenue growth for 2025 while advancing oncology and international expansion3
MiKORU Medical übertrifft im Q3 2025 die Umsatzerwartungen und hebt Prognose an2
MiKORU Medical Systems Non-GAAP EPS of $0.00 beats by $0.02, revenue of $10.4M beats by $0.73M5
MiKORU Medical Systems, Inc. - 8-K, Current Report-
KORU MEDICAL SYSTEMS Aktie jetzt für 0€ handeln
18.09.ForCast Orthopedics And KORU Medical Partner On Novel Antibiotic Infusion Therapy3
18.09.ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy242DENVER, CO AND MAHWAH, NJ / ACCESS Newswire / September 18, 2025 / ForCast Orthopedics, Inc. and KORU Medical Systems, Inc. (NASDAQ:KRMD) today jointly announced an agreement leveraging KORU Medical's...
► Artikel lesen
13.08.KORU Medical auf Wachstumskurs: Internationale Expansion und neue Produkte im Fokus1
07.08.Koru Medical Systems übertrifft im zweiten Quartal 2025 die Erwartungen1
07.08.KORU Medical Systems raises 2025 revenue outlook to $39.5M-$40.5M with accelerating international growth and new drug pipeline milestones1
06.08.KORU Medical Systems, Inc. - 10-Q, Quarterly Report1
07.07.KORU Medical appoints Adam Kalbermatten as chief commercial officer1
11.06.KORU Medical Systems to join Russell 3000 and 2000 indexes1
13.01.KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter154MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2